, Tracking Stock Market Picks
Enter Symbol:
Genuine Parts Company (GPC) [hlAlert]

up 111.68 %

Genuine Parts Company (GPC) rated Buy

Posted on: Monday,  Jan 21, 2008  9:44 PM ET by Barrons 24 Stocks Worth Buying

Barrons 24 Stocks Worth Buying rated Buy Genuine Parts Company (NYSE: GPC) on 01/21/2008, when the stock price was $39.46.
Since then, Genuine Parts Company has gained 111.68% as of 01/14/2016's recent price of $83.53.
If you would have followed this Barrons 24 Stocks Worth Buying's recommendation on GPC, you would have gained 111.68% of your investment in 2915 days.

Genuine Parts Company Biotech AG is a publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs. GPC Biotech's lead product candidate satraplatin is an oral platinum-based compound that has shown highly statistically significant results for progression-free survival in a Phase three registrational trial as a second-line chemotherapy treatment in hormone-refractory prostate cancer. The U.S. FDA has granted fast track designation to satraplatin for this indication, and the rolling NDA submission process for this compound has been completed. Satraplatin was in-licensed from Spectrum Pharmaceuticals, Inc. GPC Biotech is also developing a monoclonal antibody with a novel mechanism-of-action against a variety of lymphoid tumors, currently in Phase 1 clinical development, and has ongoing drug development and discovery programs that leverage its expertise in kinase inhibitors.

What bear market? Barrons investments pros find 24 stocks to buy in 2008, in a multitude of sectors. Included in these recommendations, Barrons recommend to BUY: DYHOL.Turkey Dogan Yayin, BISA3.Brazil, III.UK 3i Group, NFDS.UK Northern Food, FKI.UK FKI, VIV.France Vivendi, and RI.France Pernod Ricard. Also recommend to short (SELL): British Pound
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/21/2008 4:00 PM Buy
1 year
as of 12/24/2008
1 Week up  1.60 %
1 Month up  15.36 %
3 Months up  8.51 %
1 YTD down  -12.55 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy